Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was EGP 392 million compared to EGP 343.06 million a year ago. Net income was EGP 66.51 million compared to EGP 71.8 million a year ago.

Basic earnings per share from continuing operations was EGP 0.0446 compared to EGP 0.0472 a year ago. Diluted earnings per share from continuing operations was EGP 0.0443 compared to EGP 0.0472 a year ago.